| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |